Poland· PL-100450388
Tadomon
A tapentadol product containing tapentadolum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tapentadol is registered in 17 of 19 countries.
Countries holding a registration under ATC N02AX06 (tapentadol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Tapentadol · ATC N02AX06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tapentadol costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $2.14 in Italy to $6.62 in Switzerland — a ×3.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tapentadol · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.62
- ES Spain$3.34
- IT Italy$2.14
The record
At a glance
URPL (Poland)- Active substance
- Tapentadolum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- N02AX06
- ATC class
- Tapentadol
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 12
1 priced- gtin0900873201751960 szt.PLN 81.29
- gtin08436046015166
- gtin08436046015289
- gtin08436046015340
- gtin08436046015401
- gtin08436046015227
- gtin05909991535209
- gtin09008732017526
- gtin09008732017502
- gtin09008732017496
- gtin09008732017489
- gtin09008732017472
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
184 interactions on record for tapentadol.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tapentadol · interactions on record
184 records
- 30 severe
- 130 moderate
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tapentadol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOLUPRENMedochemie Ltd., Limassol
- United KingdomAtiondo SR 50mg tabletsGrunenthal Ltd
- SpainPALEXIA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADAGrünenthal Pharma S.A.
- SwedenPalexia Depot 50 mg Depottablett2care4 ApS
- NetherlandsDolten retard 50 mg tabletten met verlengde afgifteMedochemie Limited
- IrelandPalexia SR 50 mg prolonged-release tabletsGrunenthal Pharma Limited.
- BelgiumPalexia Retard 50 mgGrunenthal
- ItalyPALEXIAGRUNENTHAL ITALIA S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Palexia, Palexia Retard
- Belgium · Palexia, Palexia Retard
- Cyprus · Dolten, Dolten Retard
- Czechia · Apeneta, Dolupren
- Germany · Palexia, Palexia Akutschmerz
- Denmark · Palexia, Palexia Depot
- Estonia · Tapemed Retard
- Spain · Palexia, Palexia Retard
- United Kingdom (Northern Ireland) · Ationdo, Ationdo Sr
- Greece · Dolupren, Dolupren Ir
- Croatia · Apeneta, Dolten
- Hungary · Adoben
- Ireland · Apeneta, Palexia
- Iceland · Tapentadol Stada
- Italy · Palexia, Taboxea
- Luxembourg · Palexia, Palexia Retard
- Malta · Dolten, Dolten Retard
- Netherlands · Palexia, Palexia Retard
- Norway · Palexia, Palexia Depot
- Portugal · Ationdo, Palexia
- Romania · Dolten
- Sweden · Palexia, Palexia Depot
- Slovenia · Apeneta, Palexia
- Slovakia · Apeneta, Dolten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa78281c-906b-4df4-b8a2-534ef56c87e7 GET /v1/drugs/fa78281c-906b-4df4-b8a2-534ef56c87e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "50 mg",
"packaging": "08436046015166 ¦ Rpw ¦ Skasowane ¦ 146773\n7 tabl.\n08436046015289 ¦ Rpw ¦ Skasowane ¦ 146774\n30 tabl.\n08436046015340 ¦ Rpw ¦ Skasowane ¦ 146775\n60 tabl.\n08436046015401 ¦ Rpw ¦ Skasowane ¦ 146776\n100 tabl.\n08436046015227 ¦ Rpw ¦ Skasowane ¦ 146777\n28 tabl.\n05909991535209 ¦ Rpw ¦ Skasowane ¦ 153767\n40 tabl.\n09008732017526 ¦ Rpw ¦ 156975\n100 tabl.\n09008732017489 ¦ Rpw ¦ 156976\n28 tabl.\n09008732017519 ¦ Rpw ¦ 156977\n60 tabl.\n09008732017502 ¦ Rpw ¦ 156978\n40 tabl.\n09008732017496 ¦ Rpw ¦ 156979\n30 tabl.\n09008732017472 ¦ Rpw ¦ 156980\n7 tabl.",
"substance": "Tapentadoli tartras 83.905 mg",
"common_name": "Tapentadolum",
"pl_product_id": "100450388",
"pozwolenie_nr": "27336",
"auth_procedure": "DCP",
"authorisation_validity": "2027-09-07"
}See everything about tapentadol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.